Scholars Central

Research articlePublished 16 Mar 2021

3D carotid ultrasound in patients with a negative exercise stress test: A practical risk stratification tool

Authors: Kevin R Bainey, Jissy Thomas, Suhaib Alkurtass, Gabor T Gyenes, Yinggan Zheng, Hayrapet Kalashyan, Lucille Lalonde, Victoria Sarban, Harald Becher

Clinical Cardiology Journal

Volume 5 · Issue 2 · Pages 10–16

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Exercise stress tests (EST) are frequently used to evaluate chest pain. While a negative EST is reassuring, further risk stratification for coronary artery disease (CAD) may be warranted. Three-dimensional (3D) carotid ultrasound is a non-invasive tool which can be used to identify subclinical atherosclerotic disease. We investigated the prevalence and extent of subclinical atherosclerotic lesions using 3D carotid ultrasound in patients with chest pain and a negative EST, with the aim of understanding the changes in atherosclerotic lesions with statin therapy at 1 year. Methods: 80 patients were prospectively enrolled and all received additional vascular assessment with 3D carotid ultrasound. If subclinical atherosclerosis was identified, high-dose statin therapy was recommended. A 3D carotid ultrasound scan was repeated at 12 months. Results: Of our cohort, 37 patients (46.3%) had carotid plaque. At baseline, median plaque volume (IQR) (left carotid, right carotid, or both) was 32.0 mm3 (17-123). At 12-month follow-up (n=22), median plaque volume was 116.0 mm3 (46-279) (p=0.004). Of these, only 40.9% were on high-dose statin therapy. Total plaque volume remained stable in subjects on statins (46.5 mm3 [25-97.5] at baseline; 50 mm3 [29-131] at 12 months, p=0.596) while it increased in those without statins (20 mm3 [10-31] at baseline; 117 mm3 [78-279] at 12 months, p=0.003). Conclusion: In patients with chest pain and a negative EST, roughly one-half have subclinical atherosclerosis as detected with 3D carotid ultrasound. Plaque progression commonly occurs at 12 months, but is less likely with statin therapy. A further randomized study is required to confirm our findings.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Cardiology Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Cardiology Journal
  • SubjectCardiology
  • BylineArticles whose byline prints “Kevin R Bainey”
  • BylineArticles whose byline prints “Jissy Thomas”
  • BylineArticles whose byline prints “Suhaib Alkurtass”
  • BylineArticles whose byline prints “Gabor T Gyenes”
  • BylineArticles whose byline prints “Yinggan Zheng”
  • BylineArticles whose byline prints “Hayrapet Kalashyan”
  • BylineArticles whose byline prints “Lucille Lalonde”
  • BylineArticles whose byline prints “Victoria Sarban”